158 related articles for article (PubMed ID: 38632134)
1. Sociodemographic factors and Child Opportunity Index disparities associated with missed care opportunities in pediatric patients with lymphoma and leukemia referred for FDG-PET/CT.
Harrington S; Kwatra N; Melvin P; Tartarilla AB; Whitley MY; Valencia VF; Ward VL
Pediatr Radiol; 2024 May; 54(6):1022-1032. PubMed ID: 38632134
[TBL] [Abstract][Full Text] [Related]
2. Racial and ethnic disparities in pediatric magnetic resonance imaging missed care opportunities.
Shah SN; Melvin P; Tennermann NW; Ward VL
Pediatr Radiol; 2022 Aug; 52(9):1765-1775. PubMed ID: 35930081
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic and Clinical Demography of Dental Missed Care Opportunities.
Discepolo K; Melvin P; Ghazarians M; Tennermann N; Ward VL
JDR Clin Trans Res; 2023 Oct; 8(4):356-366. PubMed ID: 35722931
[TBL] [Abstract][Full Text] [Related]
4. 18F-2-fluoro-2-deoxyglucose uptake in white adipose tissue on pediatric oncologic positron emission tomography (PET)/computed tomography (CT).
Wong KK; Sedig LK; Bloom DA; Hutchinson RJ; Shulkin BL
Pediatr Radiol; 2020 Apr; 50(4):524-533. PubMed ID: 31776602
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging for Predicting Venous Thromboembolism in Children With Lymphoma.
Beall M; Deep K; Tram NK; Nabavinia M; Janse SA; Chou TH; Hardisky D; Bobbey AJ; Kerlin BA; Audino AN; Stacy MR
Circ Cardiovasc Imaging; 2023 Apr; 16(4):e014992. PubMed ID: 37013817
[TBL] [Abstract][Full Text] [Related]
6. Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.
Bouard L; Bodet-Milin C; Bailly C; Guillaume T; Peterlin P; Garnier A; Bourgeois AL; Mahé B; Dubruille V; Blin N; Touzeau C; Gastinne T; Lok A; Bonnet A; Béné MC; Gouill SL; Moreau P; Kraeber-Bodéré F; Chevallier P
Biol Blood Marrow Transplant; 2019 May; 25(5):906-911. PubMed ID: 30481598
[TBL] [Abstract][Full Text] [Related]
7.
Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
[TBL] [Abstract][Full Text] [Related]
8. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
9. PET/CT and renal pathology: a blind spot for radiologists? Part 2--lymphoma, leukemia, and metastatic disease.
Zukotynski K; Lewis A; O'Regan K; Jacene H; Sakellis C; Almodovar S; Israel D
AJR Am J Roentgenol; 2012 Aug; 199(2):W168-74. PubMed ID: 22826418
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC).
Fallanca F; Alongi P; Incerti E; Gianolli L; Picchio M; Kayani I; Bomanji J
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1837-48. PubMed ID: 27154522
[TBL] [Abstract][Full Text] [Related]
11. Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival.
Dai N; Liu H; Deng S; Sang S; Wu Y
Technol Cancer Res Treat; 2021; 20():15330338211056478. PubMed ID: 34806464
[No Abstract] [Full Text] [Related]
12. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
Ponisio MR; McConathy J; Laforest R; Khanna G
Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
[TBL] [Abstract][Full Text] [Related]
14. The clinical utility of fluorodeoxyglucose-positron emission tomography for investigation of fever in immunocompromised children.
Wang SS; Mechinaud F; Thursky K; Cain T; Lau E; Haeusler GM
J Paediatr Child Health; 2018 May; 54(5):487-492. PubMed ID: 29235187
[TBL] [Abstract][Full Text] [Related]
15. Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma.
Qi Z; Gates EL; O'Brien MM; Trout AT
Pediatr Radiol; 2018 Feb; 48(2):196-203. PubMed ID: 29080987
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma.
Badr S; Kotb M; Elahmadawy MA; Moustafa H
Clin Nucl Med; 2018 Dec; 43(12):e428-e438. PubMed ID: 30358625
[TBL] [Abstract][Full Text] [Related]
17. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
Albano D; Patti C; Lagalla R; Midiri M; Galia M
J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.
Vaarwerk B; Breunis WB; Haveman LM; de Keizer B; Jehanno N; Borgwardt L; van Rijn RR; van den Berg H; Cohen JF; van Dalen EC; Merks JH
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012325. PubMed ID: 34753195
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. Staging in childhood lymphoma: differences between FDG-PET and CT.
Hermann S; Wormanns D; Pixberg M; Hunold A; Heindel W; Jürgens H; Schober O; Franzius C
Nuklearmedizin; 2005 Feb; 44(1):1-7. PubMed ID: 15711722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]